Acute Hyponatraemia Protocol Adrogue-Madias Kinetics, Severity Gating & ODS Prevention · v2.0
⚠ Clinical Intelligence Engine: This tool does NOT blindly calculate an infusion rate for every sodium value. It first classifies severity, determines whether active IV correction is clinically indicated at all, and gates the output accordingly. Mild hyponatraemia will NOT receive an infusion protocol.
1. Patient Baseline
2. Aetiology, Acuity & Risk Modifiers
3. Infusate Selection

This selection applies only if active IV correction is clinically indicated. The engine will gate this decision.

Osmotic Demyelination Syndrome (ODS): The Overcorrection Catastrophe

ODS (formerly "central pontine myelinolysis") occurs when chronic hyponatraemia is corrected too rapidly. In chronic hyponatraemia, brain cells adapt by losing organic osmolytes. If extracellular Na rises too fast, water is pulled out of adapted neurons, causing demyelination. Symptoms appear 2 to 6 days after overcorrection: dysarthria, dysphagia, quadriparesis, "locked-in syndrome," and potentially death. ODS is irreversible. Prevention is the only strategy.

⚠ Golden Rule: In chronic hyponatraemia, do NOT raise sodium by more than 8 mEq/L in 24 hours (or 6 mEq/L in high-risk patients). If overcorrection occurs, actively re-lower sodium with D5W infusion or desmopressin (DDAVP 2 mcg IV q8h).
Algorithm Architecture & Clinical Traps
⚠ Common Hazard Warning (Indian ER Context)
Empirically starting an IV drip of 3% Hypertonic Saline without meticulously calculating Total Body Water or strictly defining the patient's volume status is a dangerous practice that commonly leads to ODS. 3% Saline is a highly potent drug. Continuous infusions must be strictly monitored in an ICU/HDU setting with 2 to 4 hourly ABG/VBG electrolytes.
Severity Classification & Management Tiers

Not every patient with Na⁺ < 135 needs IV correction. This tool gates its output based on severity and clinical context:

Na⁺ RangeSeverityDefault Management
130 to 134MildNo IV correction. Fluid restriction (eu/hyper) or NS volume resuscitation (hypo). Investigate cause.
125 to 129ModerateFluid restriction primary (eu/hyper). Active IV correction only if severely symptomatic or trending down.
120 to 124SevereActive correction indicated. ICU/HDU admission. Calculated infusion.
110 to 119ProfoundUrgent active correction. ICU mandatory. Consider DDAVP clamping.
< 110CriticalLife-threatening emergency. ICU, bolus protocol if symptomatic, strict monitoring.
Acute vs Chronic: The 48-Hour Rule
ChronicityODS RiskCorrection Approach
Acute (<48h)Very LowMore aggressive correction permitted (up to 10 mEq/L/24h). Brain has not adapted.
Chronic (>48h)HIGHStrict slow correction (8 mEq/L/24h max, 6 for high-risk). Brain has adapted by expelling osmolytes.
Unknown DurationTreat as ChronicIf you cannot prove onset was <48h with prior normal labs, assume chronic.
The Absolute Limits of Correction
ScenarioMax 24h RiseNotes
Standard Risk, Chronic/Unknown8 mEq/LEuropean (2014) and API (2019) consensus
High Risk (SHAM), Chronic/Unknown6 mEq/LSterns 2015
Documented Acute, Standard Risk10 mEq/LODS risk very low
Documented Acute, High Risk8 mEq/LStill apply caution despite acuity
Volume Status: The Key Branching Point
Volume StatusClinical Script & TrapsPrimary Action
Hypovolaemic Dry mucosa, flat JVP, tachycardia. Trap: Once volume is restored with NS, ADH shuts off, kidneys dump free water, Na⁺ skyrockets past the safe limit. NS to restore volume. Monitor closely for auto-correction. Consider prophylactic DDAVP clamping.
Euvolaemic Normal exam. Think SIADH, hypothyroidism, adrenal insufficiency. Trap: NS can paradoxically worsen SIADH. Always check TSH and morning cortisol first. Fluid restriction (800-1000 mL/day). HTS only if severely symptomatic.
Hypervolaemic Oedema, raised JVP, ascites. Total body Na⁺ is high but water is massively higher. Fluid restriction + Loop Diuretics. NEVER give continuous saline.
Mnemonic: "SHAM" for High ODS Risk

Patients at highest risk for ODS require the strict 6 mEq/L/24hr limit. Remember SHAM:

  • S - Severe baseline hyponatraemia (< 105 mEq/L)
  • H - Hypokalaemia (concurrent)
  • A - Alcoholism / Advanced Liver Disease
  • M - Malnutrition (severe)
3% Hypertonic Saline: Practical Guide

3% NaCl contains 513 mEq/L of Na. It is used for symptomatic hyponatraemia (seizures, coma) to rapidly raise Na by 1 to 2 mEq/L per hour for the first 2 to 3 hours.

Fixed bolus (preferred for emergencies): 150 mL of 3% NaCl IV over 20 minutes. Recheck Na after 20 minutes. Repeat up to 2 more times if symptoms persist (maximum 3 boluses). Each 150 mL bolus raises Na by approximately 1.5 to 2 mEq/L in a 70 kg patient.

⚠ 3% NaCl is not available in all Indian hospitals. Prepare by adding 30 mL of NaCl 23.4% to 470 mL NS. Label clearly. Administer via infusion pump with mandatory Na monitoring every 2 hours.
Key Clinical Traps ⚠ The Potassium Trap

Correcting hypokalaemia simultaneously raises serum Na⁺. K⁺ enters cells and displaces Na⁺ outward. Every 1 mEq of K⁺ replaced has the same osmotic effect as 1 mEq of Na⁺ infused. K⁺ correction must be counted against the 24h Na⁺ correction limit.

⚠ The Normal Saline Trap in SIADH

In SIADH, kidneys maximally concentrate urine. If you infuse 1 litre of 0.9% NS (154 mEq Na⁺ in 1000 mL), the kidneys may excrete those 154 mEq in only 500 mL of concentrated urine, retaining 500 mL of electrolyte-free water. Net effect: you have worsened the hyponatraemia despite giving sodium.

Proactive DDAVP Clamping Strategy

Modern best practice advocates proactive DDAVP clamping rather than reactive rescue. Give DDAVP 1 to 2 mcg IV at the start of therapy, then administer HTS at a calculated rate. This converts the patient into a "closed system" that behaves as the Adrogue-Madias formula predicts. Especially important for hypovolaemic patients at highest risk of auto-correction overshoot.

Pseudohyponatraemia & Dilutional Hyponatraemia

Hypertonic hyponatraemia: Hyperglycaemia pulls water out of cells, diluting sodium. For every 100 mg/dL rise in glucose above 100, Na drops by 1.6 mEq/L. Corrected Na = Measured Na + 1.6 × ((Glucose - 100) / 100). If corrected Na is normal, treat the hyperglycaemia, not the sodium.

Isotonic hyponatraemia: Severe hyperlipidaemia or hyperproteinaemia (myeloma). Serum osmolality will be normal. Not true hyponatraemia.

SIADH: Diagnosis & Management

Diagnostic criteria: (1) Serum Na < 135, (2) Serum osmolality < 275, (3) Urine osmolality > 100, (4) Urine Na > 40, (5) Euvolaemic, (6) Normal thyroid and adrenal function. Common causes in India: CNS infections (TB meningitis, encephalitis), lung disease (TB, pneumonia, lung cancer), drugs (SSRIs, Carbamazepine, Cyclophosphamide).

Management: (1) Fluid restriction (800 to 1000 mL/day). (2) Salt tablets (NaCl 3g TDS with meals). (3) Tolvaptan 15 mg PO daily if fluid restriction fails (Indian brands: Tolva, Natrise). Start in hospital with Na monitoring every 6 hours. (4) Treat the underlying cause.

Adrogue-Madias Formula & Infusate Concentrations

ΔNa⁺ = (Infusate Na⁺ - Serum Na⁺) / (Total Body Water + 1)

Limitation: Assumes zero renal water handling. Systematically underestimates correction in hypovolaemic patients and may overestimate in SIADH.

IV FluidNa⁺ (mEq/L)Typical Use
3% HTS513ICU bolus and infusion for symptomatic hyponatraemia
1.6% HTS274Peripheral line option
0.9% NS154Volume resuscitation in hypovolaemic hyponatraemia
Ringer's Lactate130Mild hypovolaemia
🔨 Overcorrection Rescue Protocol
  1. Stop all sodium-containing IV fluids and K⁺ replacement immediately.
  2. Give D5W at 6 mL/kg IV over 1 to 2 hours.
  3. Give DDAVP 2 mcg IV every 8 hours.
  4. Re-check serum Na⁺ every 1 to 2 hours until stabilised.
  5. Goal: Re-lower Na⁺ back to within the originally intended limit. Do not hesitate to re-lower - ODS risk from overcorrection far outweighs transient re-lowering risk.
Abbreviations: Na⁺ (Sodium) · K⁺ (Potassium) · ODS (Osmotic Demyelination Syndrome) · TBW (Total Body Water) · SIADH (Syndrome of Inappropriate ADH) · D5W (5% Dextrose) · DDAVP (Desmopressin) · HTS (Hypertonic Saline) · NS (Normal Saline)
Algorithm References & Evidence Base
  1. Verma A, et al. API Expert Consensus on Management of Hyponatraemia. JAPI. 2019.
  2. Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342(21):1581-1589.
  3. Spasovski G, et al. Clinical practice guideline on hyponatraemia. Eur J Endocrinol. 2014;170(3):G1-47.
  4. Sterns RH. Disorders of Plasma Sodium. N Engl J Med. 2015;372(1):55-65.
  5. Perianayagam A, et al. DDAVP for overcorrection prevention. CJASN. 2008;3(2):331-336.
  6. Sterns RH, et al. ODS following correction of hyponatremia. N Engl J Med. 1986;314(24):1535-1542.
  7. Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 Suppl 1):S1-S42.
How to Cite This Tool

AMA Style:
Umakanth S. Acute Hyponatraemia Protocol. MEDiscuss. Published 2026. Accessed .

Vancouver Style:
Umakanth S. Acute Hyponatraemia Protocol [Internet]. MEDiscuss.org; 2026 [cited ]. Available from:

Category Therapeutic Pathways & Algorithms
Specialties Internal Medicine, Nephrology, Critical Care
Status New Pathway